These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8021699)

  • 1. Successful immunosuppressive therapy for HTLV-I associated myelopathy.
    Misra AK; Mishra SK; Eigen AC; Tourtellotte WW
    J Neurol Sci; 1994 Apr; 122(2):155-6. PubMed ID: 8021699
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tropical spastic paraparesis/HTLV-I associated myelopathy. Report of 2 cases diagnosed in Cuiabá, Mato Grosso, Brazil].
    Grzesiuk AK; Martins Pde D
    Arq Neuropsiquiatr; 1999 Sep; 57(3B):870-2. PubMed ID: 10751927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol.
    Harrington WJ; Sheremata WA; Snodgrass SR; Emerson S; Phillips S; Berger JR
    AIDS Res Hum Retroviruses; 1991 Dec; 7(12):1031-4. PubMed ID: 1812944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple clinical manifestation of HTLV1 infection in a single patient.
    Narayan D; DaSilva D; Doshi M
    West Indian Med J; 2003 Dec; 52(4):322-4. PubMed ID: 15040072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potentially treatable subacute forms of infection due to the HTLV-1].
    Carod-Artal FJ; Melo M; Alves R; Brenner C; del Negro MC
    Rev Neurol; 2000 Jul 1-15; 31(1):32-5. PubMed ID: 10948579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmapheresis to treat human T lymphotropic virus type I-associated myelopathy.
    Matsuo H; Nakamura T; Shibayama K; Motomura M; Nagasato K; Takeo G; Tsujihata M; Nagataki S
    Curr Stud Hematol Blood Transfus; 1990; (57):198-207. PubMed ID: 2272201
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myelopathy associated with HTLV-1: clinical electrophysiologic study].
    Matsumoto SC; Nakasato O; Kataoka A; Inayoshi S; Okajima T
    Neurologia; 1993 Nov; 8(9):291-4. PubMed ID: 8297621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful 2-year therapy with systemic interferon-alpha for HTLV-I associated myelopathy.
    Gazzola P; Cocito L; De Maria A; Gabutti G; Mancardi GL
    J Neurol Sci; 1999 Jan; 162(2):205-7. PubMed ID: 10202989
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy.
    Kataoka A; Imai H; Inayoshi S; Tsuda T
    J Neurol Neurosurg Psychiatry; 1993 Nov; 56(11):1213-6. PubMed ID: 8229033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
    Boostani R; Vakili R; Hosseiny SS; Shoeibi A; Fazeli B; Etemadi MM; Sabet F; Valizade N; Rezaee SA
    Neurotherapeutics; 2015 Oct; 12(4):887-95. PubMed ID: 26174324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of zidovudine on chronic myelopathy associated with HTLV-1.
    Gout O; Gessain A; Iba-Zizen M; Kouzan S; Bolgert F; de Thé G; Lyon-Caen O
    J Neurol; 1991 Apr; 238(2):108-9. PubMed ID: 1856736
    [No Abstract]   [Full Text] [Related]  

  • 12. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
    J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
    Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tropical spastic paraparesis in a non tropical region].
    Pias-Peleteiro L; Pias-Peleteiro JM; Arias M
    Rev Neurol; 2015 Oct; 61(8):357-62. PubMed ID: 26461129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tropical spastic paraparesis treated with Combivir (lamivudine-zidovudine).
    Hassan S; Amer S; Zervos M
    J Clin Neurosci; 2013 May; 20(5):759-60. PubMed ID: 23477875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study.
    Yamasaki K; Kira J; Koyanagi Y; Kawano Y; Miyano-Kurosaki N; Nakamura M; Baba E; Suzuki J; Yamamoto A; Yamamoto N; Kobayashi T
    J Neurol Sci; 1997 Apr; 147(2):135-44. PubMed ID: 9106118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathy.
    Pot C; Chizzolini C; Vokatch N; Tiercy JM; Ribi C; Landis T; Perren F
    Arch Neurol; 2006 Sep; 63(9):1318-20. PubMed ID: 16966512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil.
    da Silva JL; Primo JR; de Oliveira Mde F; Batista Eda S; Moreno-Carvalho O; Farré L; Bittencourt AL
    J Clin Virol; 2013 Oct; 58(2):482-5. PubMed ID: 23932323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy.
    Shirabe S; Nakamura T; Tsujino A; Nishiura Y; Furuya T; Goto H; Suenaga A; Nakane S; Yoshimura T; Nagataki S
    J Neurol Sci; 1997 Oct; 151(1):97-101. PubMed ID: 9335018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.